IDEAYA Biosciences, Inc. IDYA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$140.06M+54.4% | -$113.7M+58.6% | -$160.74M+9.8% | -$331.8M-116% | -$307.08M-138% | ||
| $2.79M+17.6% | $2.7M+13.1% | $2.55M+4.4% | $2.47M-1.6% | $2.37M-5.3% | ||
| $50.41M+30.4% | $46.12M+32.7% | $43.81M+45.7% | $40.81M+56.1% | $38.67M+82.9% | ||
| —— | $0— | -$2K+100.0% | $17K+111% | $3K+101% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $17.5M+59.1% | $12.89M+22.5% | $14.94M+1,813% | ||
| $3.04M-39.2% | $8.03M+30.4% | $4.19M-18.9% | $5.14M— | $5M— | ||
| —— | —— | —— | —— | —— | ||
| $1.82M+19.9% | $1.89M+30.8% | $1.49M-16.0% | $1.55M-9.8% | $1.51M-6.9% | ||
| -$85.93M+67.5% | -$71.1M+71.3% | -$102.26M+31.7% | -$293.71M-125% | -$264.11M-101% | ||
| $2.01M-48.1% | $2.37M-38.6% | $3.14M-12.7% | $3.55M-5.0% | $3.86M+5.8% | ||
| $545.29M-33.6% | $607.89M-49.0% | $708.79M-34.1% | $783.53M-17.0% | $820.74M-17.9% | ||
| $656.41M-13.2% | $680.23M-1.8% | $682.32M+3.1% | $695.67M+15.6% | $755.83M+61.8% | ||
| —— | —— | -$29.61M— | -$91.41M— | —— | ||
| $56K+100% | $0-100% | $1.93M-99.5% | $276.23M+117% | -$67.83M-111% | ||
| $4.82M-98.6% | $29.78M-95.6% | $30.4M-96.3% | $316.61M-43.2% | $354.58M-50.0% | ||
| —— | —— | —— | —— | $21.7M-48.0% | ||
| —— | $0-100% | $0-100% | $3K-95.4% | $13K-80.9% | ||
| $7.41M-64.2% | $9.98M-57.1% | $13.37M-39.8% | $16.75M-17.9% | $20.7M+26.9% | ||
| —— | —— | $17.5M+59.1% | $12.89M+22.5% | $14.94M+1,813% | ||
| —— | $5.97M— | $4.48M+30.3% | $2.99M-56.6% | $1.49M-85.5% | ||
| $2.63M+998% | $2.56M+287% | $1.8M+202% | $874K+144% | -$293K+84.5% | ||
| $3.04M-39.2% | $8.03M+30.4% | $4.19M-18.9% | $5.14M— | $5M— | ||
| $1.82M+19.9% | $1.89M+30.8% | $1.49M-16.0% | $1.55M-9.8% | $1.51M-6.9% | ||
| $656.41M-13.2% | $680.23M-1.8% | $682.32M+3.1% | $695.67M+15.6% | $755.83M+61.8% | ||
| —— | —— | —— | —— | —— | ||
| $1.64M-21.6% | $1.09M-32.6% | $858K-45.1% | $2.09M+874% | $2.09M— | ||
| —— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$87.93M+67.2% | -$73.47M+70.8% | -$105.39M+31.2% | -$297.26M-121% | -$267.98M-98.7% | ||
| -$87.93M+67.2% | -$73.47M+70.8% | -$105.39M+31.2% | -$297.26M-121% | -$267.98M-98.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does IDEAYA Biosciences, Inc. generate?
- IDEAYA Biosciences, Inc. (IDYA) generated -$85.9M in operating cash flow over the trailing twelve months.
- What is IDEAYA Biosciences, Inc.'s free cash flow?
- After $2.0M of capital expenditures, IDEAYA Biosciences, Inc.'s free cash flow was -$87.9M over the trailing twelve months, up 67.2% year over year.
- Where does IDEAYA Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
